COVID-19 and Its Association with Conjunctivitis
What is COVID-19's association with conjunctivitis?
John D. Sheppard, MD, discusses steps that pediatricians and primary care providers can take to appropriately triage and manage patients with suspected cases of bacterial or viral conjunctivitis — as well as the importance of rapid, point-of-care testing as an everyday resource.
Presented By: John D. Sheppard, MD
John D. Sheppard, MD, is an internationally recognized expert in the diagnosis and treatment of ophthalmologic disease, immunology, and preclinical science. His background provides a broad base for development of ophthalmologic drugs and devices, as well as translational research bringing preclinical studies into practice.
Omalizumab outperforms oral immunotherapy in treating multi-food allergy
March 27th 2025A new clinical trial has found that omalizumab (Xolair; Genetech, Novartis) is more effective than oral immunotherapy (OIT) in treating multi-food allergy in individuals with severe allergic reactions to small amounts of common food allergens.
